NASDAQ:NYXH Nyxoah (NYXH) Stock Price, News & Analysis $7.74 -0.58 (-6.97%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$8.18 +0.44 (+5.62%) As of 05/23/2025 05:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Nyxoah Stock (NASDAQ:NYXH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Nyxoah alerts:Sign Up Key Stats Today's Range$7.56▼$7.9350-Day Range$5.71▼$11.4752-Week Range$5.55▼$11.87Volume116,429 shsAverage Volume74,237 shsMarket Capitalization$263.62 millionP/E RatioN/ADividend YieldN/APrice Target$14.50Consensus RatingBuy Company OverviewNyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.Read More… Nyxoah Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks57th Percentile Overall ScoreNYXH MarketRank™: Nyxoah scored higher than 57% of companies evaluated by MarketBeat, and ranked 412th out of 919 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingNyxoah has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageNyxoah has only been the subject of 2 research reports in the past 90 days.Read more about Nyxoah's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Nyxoah are expected to grow in the coming year, from ($1.91) to ($1.73) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Nyxoah is -4.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Nyxoah is -4.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Nyxoah's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.80% of the float of Nyxoah has been sold short.Short Interest Ratio / Days to CoverNyxoah has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nyxoah has recently decreased by 38.19%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNyxoah does not currently pay a dividend.Dividend GrowthNyxoah does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.80% of the float of Nyxoah has been sold short.Short Interest Ratio / Days to CoverNyxoah has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Nyxoah has recently decreased by 38.19%, indicating that investor sentiment is improving significantly. News and Social Media2.6 / 5News Sentiment0.73 News SentimentNyxoah has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Nyxoah this week, compared to 2 articles on an average week.Search Interest2 people have searched for NYXH on MarketBeat in the last 30 days. MarketBeat Follows3 people have added Nyxoah to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Nyxoah insiders have not sold or bought any company stock.Percentage Held by Insiders17.11% of the stock of Nyxoah is held by insiders. A high percentage of insider ownership can be a sign of company health.Read more about Nyxoah's insider trading history. Receive NYXH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nyxoah and its competitors with MarketBeat's FREE daily newsletter. Email Address NYXH Stock News HeadlinesINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHMay 18, 2025 | gurufocus.comNyxoah outlines U.S. Genio launch plan with 50-member team as FDA approval expected Q2 2025May 16, 2025 | seekingalpha.comBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.May 24, 2025 | Crypto 101 Media (Ad)Analyzing INVO Bioscience (NASDAQ:INVO) and Nyxoah (NASDAQ:NYXH)May 16, 2025 | americanbankingnews.comNyxoah S.A. (NASDAQ:NYXH) Q1 2025 Earnings Call TranscriptMay 15, 2025 | msn.comNyxoah SA (NYXH) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesMay 15, 2025 | finance.yahoo.comNyxoah SA (NYXH) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comNyxoah Reports First Quarter Financial and Operating ResultsMay 14, 2025 | globenewswire.comSee More Headlines NYXH Stock Analysis - Frequently Asked Questions How have NYXH shares performed this year? Nyxoah's stock was trading at $8.00 at the beginning of 2025. Since then, NYXH stock has decreased by 3.3% and is now trading at $7.74. View the best growth stocks for 2025 here. How were Nyxoah's earnings last quarter? Nyxoah S.A. (NASDAQ:NYXH) released its earnings results on Wednesday, May, 14th. The company reported ($0.63) earnings per share for the quarter, missing analysts' consensus estimates of ($0.49) by $0.14. The company earned $1.12 million during the quarter, compared to analysts' expectations of $1.64 million. Nyxoah had a negative trailing twelve-month return on equity of 51.68% and a negative net margin of 1,043.93%. Read the conference call transcript. When did Nyxoah IPO? Nyxoah (NYXH) raised $83 million in an initial public offering on Friday, July 2nd 2021. The company issued 2,760,000 shares at a price of $30.00 per share. Who are Nyxoah's major shareholders? Nyxoah's top institutional shareholders include Vestal Point Capital LP (6.81%) and Kovack Advisors Inc. (0.07%). How do I buy shares of Nyxoah? Shares of NYXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Nyxoah own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nyxoah investors own include PayPal (PYPL), Confluent (CFLT), Datadog (DDOG), Baidu (BIDU), Arcadia Biosciences (RKDA), SEA (SE) and ZoomInfo Technologies (ZI). Company Calendar Last Earnings5/14/2025Today5/23/2025Next Earnings (Estimated)8/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:NYXH CIK1857190 Webwww.nyxoah.com Phone321-022-2355Fax321-045-9075Employees110Year FoundedN/APrice Target and Rating Average Stock Price Target$14.50 High Stock Price Target$16.00 Low Stock Price Target$13.00 Potential Upside/Downside+87.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($2.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-46,770,000.00 Net Margins-1,043.93% Pretax Margin-1,036.49% Return on Equity-51.68% Return on Assets-40.11% Debt Debt-to-Equity Ratio0.21 Current Ratio5.28 Quick Ratio4.95 Sales & Book Value Annual Sales$4.36 million Price / Sales60.41 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares34,060,000Free Float28,232,000Market Cap$263.62 million OptionableNot Optionable Beta1.56 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (NASDAQ:NYXH) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe “black glass” breakthrough behind AI’s next leapAI is advancing fast… But there’s one problem almost no one’s talking about. Power.True Market Insiders | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.